KOrean Borderline Ovarian Tumor (KOBOT) Registry

NCT02803970RecruitingOBSERVATIONAL

Summary

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

Key Facts

Lead Sponsor

Kangbuk Samsung Hospital

Enrollment

3000

Start Date

1994-12-01

Completion Date

2040-12-01

Study Type

OBSERVATIONAL

Official Title

Establishing the Registry of Korean Patients With Borderline Ovarian Tumors

Conditions

Ovarian Neoplasms

Eligibility

Sex

FEMALE

Inclusion Criteria:

* Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea.
* All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015

Exclusion Criteria:

* Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis

Outcome Measures

Primary Outcomes

Recurrence-free survival

Time frame: up to 100 months

Locations

Samsung Changwon Hospital, Changwon, South Korea

Kangbuk Samsung Hospital, Seoul, South Korea

CHA Gangnam Medical Center, Seoul, South Korea

Samsung Medical Center, Seoul, South Korea

Linked Diseases

Ovarian Neoplasms

Ovarian Neoplasms — a type of gynecological cancer.

KOrean Borderline Ovarian Tumor (KOBOT) Registry